Changes in PAT and QbD Investment and Implementation: 2010-2012

We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.

With budgets being cut and margins becoming tighter, PAT and Quality by Design are becoming more and more critical for the pharmaceutical industry. In a recent survey carried out by Pharma IQ,  80% said they plan to invest in PAT and QbD solutions. In preparation for the 10th Annual PAT and QbD conference, Pharma IQ has analysed the change in investment levels over the last 3 years and presents the results in this infographic.
Have Your Say
Rate this feature and give us your feedback in the comments section below